Cancer Therapeutics Market Growth Opportunities and Forecast till 2032
CHAPTER 1. Industry Overview of Cancer Therapeutics Market
1.1. Definition and Scope
1.1.1. Definition of Cancer Therapeutics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Cancer Therapeutics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Cancer Therapeutics Market By Application
1.2.3. Cancer Therapeutics Market By Top Selling Drugs
1.2.4. Cancer Therapeutics Market By End User
1.2.5. Cancer Therapeutics Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Distribution Channel
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Cancer Therapeutics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Cancer Therapeutics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2023
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Cancer Therapeutics Market By Application
4.1. Introduction
4.2. Cancer Therapeutics Revenue By Application
4.2.1. Cancer Therapeutics Market Revenue (USD Million) and Forecast, By Application, 2020-2032
4.2.2. Blood Cancer
4.2.2.1. Blood Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.3. Lung Cancer
4.2.3.1. Lung Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.4. Colorectal Cancer
4.2.4.1. Colorectal Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.5. Prostate Cancer
4.2.5.1. Prostate Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.6. Breast Cancer
4.2.6.1. Breast Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.7. Cervical Cancer
4.2.7.1. Cervical Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.8. Head and Neck Cancer
4.2.8.1. Head and Neck Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.9. Glioblastoma
4.2.9.1. Glioblastoma Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.10. Malignant Meningioma
4.2.10.1. Malignant Meningioma Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.11. Mesothelioma
4.2.11.1. Mesothelioma Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.12. Melanoma
4.2.12.1. Melanoma Market Revenue (USD Million) and Growth Rate (%), 2020-2032
4.2.13. Others
4.2.13.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 5. Cancer Therapeutics Market By Top Selling Drugs
5.1. Introduction
5.2. Cancer Therapeutics Revenue By Top Selling Drugs
5.2.1. Cancer Therapeutics Market Revenue (USD Million) and Forecast, By Top Selling Drugs, 2020-2032
5.2.2. Revlimid
5.2.2.1. Revlimid Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Avastin
5.2.3.1. Avastin Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Herceptin
5.2.4.1. Herceptin Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Rituxan
5.2.5.1. Rituxan Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.6. Opdivo
5.2.6.1. Opdivo Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.7. Gleevec
5.2.7.1. Gleevec Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.8. Velcade
5.2.8.1. Velcade Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.9. Imbruvica
5.2.9.1. Imbruvica Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.10. Ibrance
5.2.10.1. Ibrance Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.11. Zytiga
5.2.11.1. Zytiga Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.12. Alimta
5.2.12.1. Alimta Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.13. Xtandi
5.2.13.1. Xtandi Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.14. Tarceva
5.2.14.1. Tarceva Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.15. Perjeta
5.2.15.1. Perjeta Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.16. Temodar
5.2.16.1. Temodar Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.17. Others
5.2.17.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Cancer Therapeutics Market By End User
6.1. Introduction
6.2. Cancer Therapeutics Revenue By End User
6.2.1. Cancer Therapeutics Market Revenue (USD Million) and Forecast, By End User, 2020-2032
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Specialty Clinics
6.2.3.1. Specialty Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Cancer and Radiation Therapy Centers
6.2.4.1. Cancer and Radiation Therapy Centers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Cancer Therapeutics Market By Country
7.1. North America Cancer Therapeutics Market Overview
7.2. U.S.
7.2.1. U.S. Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
7.2.2. U.S. Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
7.2.3. U.S. Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
7.3. Canada
7.3.1. Canada Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
7.3.2. Canada Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
7.3.3. Canada Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Cancer Therapeutics Market By Country
8.1. Europe Cancer Therapeutics Market Overview
8.2. U.K.
8.2.1. U.K. Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
8.2.2. U.K. Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
8.2.3. U.K. Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
8.3. Germany
8.3.1. Germany Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
8.3.2. Germany Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
8.3.3. Germany Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
8.4. France
8.4.1. France Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
8.4.2. France Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
8.4.3. France Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
8.5. Spain
8.5.1. Spain Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
8.5.2. Spain Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
8.5.3. Spain Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
8.6.2. Rest of Europe Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
8.6.3. Rest of Europe Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
CHAPTER 9. Asia Pacific Cancer Therapeutics Market By Country
9.1. Asia Pacific Cancer Therapeutics Market Overview
9.2. China
9.2.1. China Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
9.2.2. China Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
9.2.3. China Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
9.3. Japan
9.3.1. Japan Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
9.3.2. Japan Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
9.3.3. Japan Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
9.4. India
9.4.1. India Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
9.4.2. India Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
9.4.3. India Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
9.5. Australia
9.5.1. Australia Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
9.5.2. Australia Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
9.5.3. Australia Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
9.6. South Korea
9.6.1. South Korea Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
9.6.2. South Korea Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
9.6.3. South Korea Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
9.7.2. Rest of Asia-Pacific Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
9.7.3. Rest of Asia-Pacific Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10.Latin America Cancer Therapeutics Market By Country
10.1. Latin America Cancer Therapeutics Market Overview
10.2. Brazil
10.2.1. Brazil Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
10.2.2. Brazil Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
10.2.3. Brazil Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
10.3. Mexico
10.3.1. Mexico Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
10.3.2. Mexico Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
10.3.3. Mexico Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
10.4.2. Rest of Latin America Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
10.4.3. Rest of Latin America Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11.Middle East & Africa Cancer Therapeutics Market By Country
11.1. Middle East & Africa Cancer Therapeutics Market Overview
11.2. GCC
11.2.1. GCC Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
11.2.2. GCC Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
11.2.3. GCC Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
11.3. South Africa
11.3.1. South Africa Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
11.3.2. South Africa Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
11.3.3. South Africa Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Cancer Therapeutics Market Revenue (USD Million) and Forecast By Application, 2020-2032
11.4.2. Rest of Middle East & Africa Cancer Therapeutics Market Revenue (USD Million) and Forecast By Top Selling Drugs, 2020-2032
11.4.3. Rest of Middle East & Africa Cancer Therapeutics Market Revenue (USD Million) and Forecast By End User, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12.Player Analysis Of Cancer Therapeutics
12.1. Cancer Therapeutics Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Cancer Therapeutics Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13.COMPANY PROFILE
13.1. AbbVie, Inc.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2023
13.1.3.2. AbbVie, Inc., 2023 Cancer Therapeutics Business Regional Distribution
13.1.4. Product / Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Astellas Pharma, Inc.
13.3. Bristol-Myers Squibb Company
13.4. Celgene Corporation
13.5. Eli Lilly and Company
13.6. F. Hoffmann-La Roche AG
13.7. Johnson & Johnson
13.8. Merck KGaA
13.9. Novartis AG
13.10. Pfizer, Inc.